Autologous/syngeneic stem cell transplantation to treat refractory GvHD
- 18 October 2004
- journal article
- research article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 34 (11), 995-998
- https://doi.org/10.1038/sj.bmt.1704658
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Severe acute graft-versus-host disease after T-cell depleted allogeneic stem cell graft from a second donor caused by persisting T-cells from the first donorBone Marrow Transplantation, 2003
- CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantationNature Medicine, 2003
- Graft-versus-host disease and outcome in HLA-identical sibling transplantations for chronic myeloid leukemia.Blood, 2002
- Tolerance induction of alloreactive T cells via ex vivo blockade of the CD40:CD40L costimulatory pathway results in the generation of a potent immune regulatory cellBlood, 2002
- The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethalityBlood, 2002
- Pseudoautologous blood stem cell transplantation for refractory chronic graft-versus-host diseaseBone Marrow Transplantation, 2002
- Chronic demyelinating polyneuropathy in graft‐versus‐host disease following allogeneic bone marrow transplantationNeuropathology, 2002
- Understanding the alloresponse: New approaches to graft-versus-host disease preventionSeminars in Hematology, 2002
- A Fas-based suicide switch in human T cells for the treatment of graft-versus-host diseaseBlood, 2001
- Prevention and treatment of graft-versus-host disease by down-regulation of anti-host reactivity with veto cells of host originBone Marrow Transplantation, 1999